J Code

ALL CODES   A CODE   B CODE   C CODE   CPT CODE   J CODE   NOC CODE   P CODE   Q CODE   S CODE  COST

LEQEMBI – J0174

LEQEMBI is an Neurology drug manufactured by Eisai and administered via the intravenous route of administration. The J Code: J0174 is aligned to the drug LEQEMBI.

Read More »

ESMOLOL HCL – J1806

ESMOLOL HCL is a Cardiology drug manufactured by WG CRITICAL CARE and administered via the Intravenous route of administration. The J Code: J1806 is aligned to the drug ESMOLOL HCL.

Read More »

MITOSOL – J7315

MITOSOL is a Ophthalmic drug manufactured by MOBIUS THERAPEUTICS and administered via the Ophthalmic route of administration. The J Code: J7315 is aligned to the drug MITOSOL.

Read More »

LUNSUMIO – J9350

LUNSUMIO is a Oncology drug manufactured by GENENTECH USA, INC. and administered via the Intravenous route of administration. The J Code: J9350 is aligned to the drug LUNSUMIO.

Read More »

INVEGA TRINZA – J2427

INVEGA TRINZA is a Psychiatric drug manufactured by JANSSEN PHARMACEUTICALS, INC. and administered via the Intramuscular route of administration. The J Code: J2427 is aligned to the drug INVEGA TRINZA.

Read More »

GANCICLOVIR – J1574

GANCICLOVIR is a Antiviral drug manufactured by EXELA PHARMA SCIENCES and administered via the Intravenous route of administration. The J Code: J1574 is aligned to the drug GANCICLOVIR.

Read More »

ALFERON N – J9215

ALFERON N is a Immunology drug manufactured by HEMISPHERX BIOPHARMA, INC. and administered via the Injection route of administration. The J Code: J9215 is aligned to the drug ALFERON N.

Read More »

REBYOTA – J1440

REBYOTA is a Fecal drug manufactured by FERRING PHARMACEUTICALS, INC. and administered via the Rectal route of administration. The J Code: J1440 is aligned to the drug REBYOTA.

Read More »

TRIFERIC – J1444

TRIFERIC is a Hematology drug manufactured by ROCKWELL MEDICAL and administered via the Route Not Applicable route of administration. The J Code: J1444 is aligned to the drug TRIFERIC.

Read More »

TECVAYLI – J9380

TECVAYLI is a Oncology drug manufactured by Janssen Biotech, Inc. and administered via the Subcutaneous route of administration. The J Code: J9380 is aligned to the drug TECVAYLI.

Read More »